SHELBY BONN: Open Payments
NPI 1285121517 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 80 payments from 15 companies in 2025. Trend: 2023 $5,660 · 2024 $3,384 · 2025 $1,718
Food & beverage: $1,718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $345 |
| Arcutis Biotherapeutics, Inc. | 14 | $338 |
| Lilly USA, LLC | 6 | $206 |
| UCB, Inc. | 3 | $146 |
| GENZYME CORPORATION | 5 | $141 |
| Organon LLC | 11 | $118 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $95 |
| Janssen Biotech, Inc. | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
Products named: Zoryve, DUPIXENT, EBGLYSS, Bimzelx, SKYRIZI, ILUMYA, TREMFYA, VTAMA.
Industry payments across TX — which companies pay providers there.
